GBE1 and lung adenocarcinoma: As one of the causes of glycogen metabolic diseases, recent studies have revealed that GBE1 affects the development and progression of a variety of tumors, such as leukemia, lung adenocarcinoma, and ovarian cancer [19,20,21].